GO.cluster	IC	GO.ID	term	definition	Aboral_elim.genes_frequency	Aboral_elim.pvalue	Aboral_elim.-log10_pvalue	Aboral_elim.Significant_genes	Aboral_elim.Significant_genes_symbol
"1"	8.51	"GO:0001527"	"microfibril"	"Extracellular matrix components occurring independently or along with elastin. Thought to have force-bearing functions in tendon. In addition to fibrillins, microfibrils may contain other associated proteins."	"37.5% (3/8)"	0.002280111	2.64	"Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___TS.g1462.t1"	"Fibrillin-2 [Cleaved into: Placensin];Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Fibrillin-1 (MP340) [Cleaved into: Asprosin]"
"1"	8.51	"GO:0005584"	"collagen type I trimer"	"A collagen trimer containing alpha(I) chains. The most common form of type I collagen is a heterotrimer containing two alpha1(I) chains and one alpha2(I) chain; homotrimers containing three alpha1(I) chains are also found. Type I collagen triple helices associate to form banded fibrils."	"62.5% (5/8)"	3.050005e-06	5.52	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"2"	8.4	"GO:0090733"	"tenascin complex"	"A extracellular matrix complex involved in cell adhesion and cell migration. Typically homotrimeric or homohexameric. In mammals, four complexes exist: Tenascin-C, Tenascin-N (also known as Tenascin-W), Tenascin-X and Tenascin-R."	"33.333% (3/9)"	0.003329147	2.48	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"2"	8.65	"GO:0120216"	"matrilin complex"	NA	"42.857% (3/7)"	0.001464103	2.83	"Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___TS.g12453.t2"	"Matrilin-4 (MAT-4);Matrilin-2;Matrilin-2"
"2"	8.98	"GO:0098965"	"extracellular matrix of synaptic cleft"	"The portion of the extracellular matrix that lies within the synaptic cleft."	"60% (3/5)"	0.0004416109	3.35	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"2"	7.95	"GO:0098966"	"perisynaptic extracellular matrix"	"The portion of the extracellular matrix that lies within the perisynaptic space."	"41.667% (5/12)"	3.825561e-05	4.42	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___TS.g5115.t2"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)"
"2"	8.19	"GO:0098644"	"complex of collagen trimers"	"A complex of collagen trimers such as a fibril or collagen network."	"63.636% (7/11)"	0.003706987	2.43	"Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1"	"Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B"
"2"	5.72	"GO:0005604"	"basement membrane"	"A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers."	"20.513% (24/117)"	2.893836e-12	11.54	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g8258.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);von Willebrand factor A domain-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrilin-2;Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Collagen alpha-2(IV) chain;Hemicentin-2;Hemicentin-2"
"2"	8.4	"GO:0005614"	"interstitial matrix"	"A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens."	"44.444% (4/9)"	0.0001820371	3.74	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___TS.g23178.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(XXVII) chain B"
"2"	4.73	"GO:0031012"	"extracellular matrix"	"A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues."	"21.032% (53/252)"	2.565964e-06	5.59	"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g1638.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1;Pocillopora_acuta_HIv2___TS.g8258.t1"	"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Collagen alpha-6(VI) chain;Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Fibrillin-2 [Cleaved into: Placensin];Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);von Willebrand factor A domain-containing protein 1;Collagen triple helix repeat-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-6(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein Wnt-7a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Spondin-1 (F-spondin);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Hemicentin-2;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Hemicentin-2"
"3"	7.1	"GO:0005796"	"Golgi lumen"	"The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks."	"24.242% (8/33)"	1.675537e-05	4.78	"Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g18622.t1b"	"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Glypican-5 [Cleaved into: Secreted glypican-5];Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]"
"3"	5.81	"GO:0005788"	"endoplasmic reticulum lumen"	"The volume enclosed by the membranes of the endoplasmic reticulum."	"10.084% (12/119)"	0.001194642	2.92	"Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g673.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30131.t1"	"Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Protein Wnt-7a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)"
"4"	6.34	"GO:0005581"	"collagen trimer"	"A protein complex consisting of three collagen chains assembled into a left-handed triple helix. These trimers typically assemble into higher order structures."	"26.984% (17/63)"	1.116414e-05	4.95	"Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1"	"Collagen alpha-6(VI) chain;Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Collagen triple helix repeat-containing protein 1;Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Collagen alpha-6(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain"
"4"	7.46	"GO:0005589"	"collagen type VI trimer"	"A collagen heterotrimer containing type VI alpha chains in alpha1(VI)alpha2(VI)alpha3(VI) trimers; type VI collagen triple helices associate to form beaded fibrils."	"17.391% (4/23)"	0.008574668	2.07	"Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1"	"Collagen alpha-6(VI) chain;Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Collagen alpha-6(VI) chain"
"5"	4.75	"GO:0097060"	"synaptic membrane"	"A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell."	"6.844% (18/263)"	0.006941719	2.16	"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g2445.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8131.t1"	"LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158)"
"5"	2.36	"GO:0005886"	"plasma membrane"	"The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins."	"5.265% (131/2488)"	0.0001372503	3.86	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.820_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g10855.t1;Pocillopora_acuta_HIv2___RNAseq.g11497.t1;Pocillopora_acuta_HIv2___RNAseq.g12088.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14240.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14366.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15948.t1;Pocillopora_acuta_HIv2___RNAseq.g15953.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18385.t1;Pocillopora_acuta_HIv2___RNAseq.g18425.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21032.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21588.t1a;Pocillopora_acuta_HIv2___RNAseq.g22691.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g24040.t1;Pocillopora_acuta_HIv2___RNAseq.g24196.t1;Pocillopora_acuta_HIv2___RNAseq.g24413.t1;Pocillopora_acuta_HIv2___RNAseq.g2445.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25184.t1;Pocillopora_acuta_HIv2___RNAseq.g25186.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g25885.t1;Pocillopora_acuta_HIv2___RNAseq.g26057.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g26319.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g27566.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1;Pocillopora_acuta_HIv2___RNAseq.g28818.t1;Pocillopora_acuta_HIv2___RNAseq.g2884.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29446.t1;Pocillopora_acuta_HIv2___RNAseq.g29795.t1;Pocillopora_acuta_HIv2___RNAseq.g30377.t2;Pocillopora_acuta_HIv2___RNAseq.g30593.t1;Pocillopora_acuta_HIv2___RNAseq.g30657.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g3094.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g3515.t1;Pocillopora_acuta_HIv2___RNAseq.g4073.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g4679.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5145.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g5871.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g775.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g829.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___RNAseq.g9054.t1;Pocillopora_acuta_HIv2___RNAseq.g9056.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9839.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12121.t1;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12848.t1;Pocillopora_acuta_HIv2___TS.g15585.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g186.t2;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g24890.t1;Pocillopora_acuta_HIv2___TS.g25584.t1;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g29372.t2;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g4840.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g7543.t1;Pocillopora_acuta_HIv2___TS.g8131.t1;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor class A member 5;Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Cell wall protein DAN4 (Delayed anaerobic protein 4);Glypican-5 [Cleaved into: Secreted glypican-5];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains);Patched domain-containing protein 3 (RND-type protein RNDEu-3);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25);Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107);Hemicentin-2;Hemicentin-2;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Synaptotagmin-3 (Synaptotagmin III) (SytIII);Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Toll-like receptor 2 (CD antigen CD282);Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);TNF receptor-associated factor 5;TNF receptor-associated factor 5;Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-);Septin-2;Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Hephaestin-like protein (EC 1.-.-.-);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Synaptotagmin-10 (Synaptotagmin X) (SytX);Aquaporin-3 (Aquaglyceroporin-3);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Phosphatidylinositol-3-phosphate phosphatase MTMR1 (EC 3.1.3.-) (Myotubularin-related protein 1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95);Zonadhesin;Rhodopsin, GQ-coupled (GQ-rhodopsin);Ras-related protein Rab-8B (EC 3.6.5.2);Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2);Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Frizzled-5 (Fz-5) (Xfz5);Ras-related protein Rab-38 (EC 3.6.5.2) (Melanoma antigen NY-MEL-1);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1);Roundabout homolog 1;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2);Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76);CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein REDUCED CHLOROPLAST COVERAGE 2 (Protein TPR-domain suppressor of STIMPY);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Scavenger receptor class A member 5;Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK);Hemicentin-1 (Fibulin-6) (FIBL-6);Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Signal peptide, CUB and EGF-like domain-containing protein 3;Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Hemicentin-2;BTB/POZ domain-containing protein KCTD7;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Trimethylamine transporter (TMA transporter) (TMA-specific transporter);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Proton-coupled folate transporter (Solute carrier family 46 member 1);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)"
"5"	6.37	"GO:0032154"	"cleavage furrow"	"The cleavage furrow is a plasma membrane invagination at the cell division site. The cleavage furrow begins as a shallow groove and eventually deepens to divide the cytoplasm."	"14.706% (10/68)"	0.0001487612	3.83	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g8258.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;Hemicentin-2;Septin-2;Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;Hemicentin-2"
"6"	4.83	"GO:0070062"	"extracellular exosome"	"A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."	"6.583% (21/319)"	0.005758438	2.24	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g5618.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Hemicentin-1 (Fibulin-6) (FIBL-6);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Roundabout homolog 2;Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Roundabout homolog 2;Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)"
"6"	3.93	"GO:0005615"	"extracellular space"	"That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."	"13.062% (90/689)"	7.058214e-32	31.15	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14257.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26590.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28450.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g31347.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g8098.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9118.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9756.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23133.t3;Pocillopora_acuta_HIv2___TS.g23144.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Tissue inhibitor of metalloproteinase;Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Bone morphogenetic protein 2 (BMP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog);Noggin-2;Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Collagen triple helix repeat-containing protein 1;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Secreted frizzled-related protein 5 (sFRP-5);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Tear acid lipase-like protein (TALLP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-8b;Protein Wnt-8a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Trypsin-3 (EC 3.4.21.4) (Trypsin III);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Equistatin (EI) (Cysteine proteinase inhibitor);Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Roundabout homolog 2;Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx);Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Collagen alpha-1(XXVII) chain B;Signal peptide, CUB and EGF-like domain-containing protein 3;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)"
"6"	3.27	"GO:0005576"	"extracellular region"	"The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."	"12.874% (159/1235)"	1.459036e-26	25.84	"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12045.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g1273.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14257.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g15172.t1;Pocillopora_acuta_HIv2___RNAseq.g15279.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15832.t1;Pocillopora_acuta_HIv2___RNAseq.g1638.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g1970.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g22262.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g22572.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g23898.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25208.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g25274.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g25890.t1;Pocillopora_acuta_HIv2___RNAseq.g25935.t1;Pocillopora_acuta_HIv2___RNAseq.g26035.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26319.t1;Pocillopora_acuta_HIv2___RNAseq.g26589.t1;Pocillopora_acuta_HIv2___RNAseq.g26590.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g28195.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28450.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28800.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g30235.t1;Pocillopora_acuta_HIv2___RNAseq.g30304.t2;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g31081.t1;Pocillopora_acuta_HIv2___RNAseq.g31347.t1;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g39.t2;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g4202.t1;Pocillopora_acuta_HIv2___RNAseq.g4746.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5347.t1;Pocillopora_acuta_HIv2___RNAseq.g5348.t1a;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g715.t1;Pocillopora_acuta_HIv2___RNAseq.g7635.t1;Pocillopora_acuta_HIv2___RNAseq.g8098.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8587.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9118.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9756.t1;Pocillopora_acuta_HIv2___TS.g10825.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12320.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g13882.t1c;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15792.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23133.t3;Pocillopora_acuta_HIv2___TS.g23144.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g26127.t2b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1;Pocillopora_acuta_HIv2___TS.g8258.t1"	"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Collagen alpha-6(VI) chain;Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Tissue inhibitor of metalloproteinase;Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);von Willebrand factor D and EGF domain-containing protein;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Bone morphogenetic protein 2 (BMP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog);Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Insoluble matrix shell protein 1 (IMSP1);Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Cell wall protein DAN4 (Delayed anaerobic protein 4);von Willebrand factor A domain-containing protein 1;Glypican-5 [Cleaved into: Secreted glypican-5];Collagen triple helix repeat-containing protein 1;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Halomucin;Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Skeletal aspartic acid-rich protein 1;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain];Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);von Willebrand factor A domain-containing protein 7 (Protein G7c);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form);Mammalian ependymin-related protein 1 (MERP-1);Secreted frizzled-related protein 5 (sFRP-5);Collagen alpha-6(VI) chain;MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1);MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2);Threonine-rich protein;Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-);Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2);Tear acid lipase-like protein (TALLP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Fibulin-2 (FIBL-2);Serine protease inhibitor dipetalogastin (Dipetalin);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Trypsin-3 (EC 3.4.21.4) (Trypsin III);Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-3;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Galaxin;Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form];Equistatin (EI) (Cysteine proteinase inhibitor);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin);Spondin-1 (F-spondin);Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)];Class II hydrophobin C;Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);Hemicentin-1 (Fibulin-6) (FIBL-6);von Willebrand factor A domain-containing protein 7 (Protein G7c);Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1);Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba; Complement factor B Bb];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module);Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Alpha-crystallin B chain (Alpha(B)-crystallin);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Acidic skeletal organic matrix protein (Acidic SOMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Collagen alpha-1(XXVII) chain B;Signal peptide, CUB and EGF-like domain-containing protein 3;Collagen alpha-2(IV) chain;Hemicentin-2;Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Hemicentin-2"
"7"	7.6	"GO:0005927"	"muscle tendon junction"	"A cell-substrate junction found at the terminal anchorage site of skeletal muscle cells to tendons."	"25% (5/20)"	0.000589738	3.23	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6)"
"7"	6.13	"GO:0005912"	"adherens junction"	"A cell-cell junction composed of the epithelial cadherin-catenin complex. The epithelial cadherins, or E-cadherins, of each interacting cell extend through the plasma membrane into the extracellular space and bind to each other. The E-cadherins bind to catenins on the cytoplasmic side of the membrane, where the E-cadherin-catenin complex binds to cytoskeletal components and regulatory and signaling molecules."	"11.494% (10/87)"	0.001115739	2.95	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g6576.t2"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Hemicentin-1 (Fibulin-6) (FIBL-6);LIM domain-containing protein jub"
"8"	5.02	"GO:0005938"	"cell cortex"	"The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins."	"8.482% (19/224)"	0.0004742814	3.32	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.820_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g16665.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g7219.t1;Pocillopora_acuta_HIv2___RNAseq.g7635.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9554.t1;Pocillopora_acuta_HIv2___TS.g14217.t2;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g6576.t2;Pocillopora_acuta_HIv2___TS.g7543.t1;Pocillopora_acuta_HIv2___TS.g8258.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);Hemicentin-1 (Fibulin-6) (FIBL-6);Cortactin-binding protein 2 (CortBP2);Hemicentin-2;Hemicentin-2;Septin-2;Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Cortactin-binding protein 2 (CortBP2);Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1);Hemicentin-1 (Fibulin-6) (FIBL-6);CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein);TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;LIM domain-containing protein jub;SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains);Hemicentin-2"
"8"	6.42	"GO:0098685"	"Schaffer collateral - CA1 synapse"	"A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell."	"13.846% (9/65)"	0.0005032783	3.3	"Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g16928.t3;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g4983.t1"	"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)"
"8"	4.59	"GO:0045177"	"apical part of cell"	"The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue."	"6.832% (22/322)"	0.003057013	2.51	"Pocillopora_acuta_HIv2___RNAseq.g11497.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g16928.t3;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g4840.t1;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g6576.t2;Pocillopora_acuta_HIv2___TS.g7543.t1"	"Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Proton-coupled folate transporter (Solute carrier family 46 member 1);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);LIM domain-containing protein jub;SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)"
"8"	4.82	"GO:0009986"	"cell surface"	"The external part of the cell wall and/or plasma membrane."	"9.492% (28/295)"	2.699179e-06	5.57	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g1273.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18763.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23673.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);von Willebrand factor D and EGF domain-containing protein;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-7a;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Roundabout homolog 1;Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Signal peptide, CUB and EGF-like domain-containing protein 3"
